Burst wave lithotripsy for the treatment of obstructive ureteroliths in cats.

Authors

Adam Hunt, Adam D Maxwell, Jody P Lulich, Michael R Bailey, Kaizer Contreras, Ga Won Kim, Richard Hermes, Marissa Y Torre, Michael S Borofsky, Eva Furrow

Published in

Journal of veterinary internal medicine. Volume 40. Issue 4. Jul 01, 2026.

Abstract

Ureteroliths are a major source of morbidity and mortality in cats, and limited non-surgical options are available for their treatment. Ultrasound-guided, burst wave lithotripsy (BWL) is approved by the Food and Drug Administration to fragment renal and ureteral calculi noninvasively in awake human patients.
Assess the safety and efficacy of a veterinary BWL device for the treatment of obstructive ureteroliths in cats.
Eleven client-owned cats; 10 with unilateral ureteral obstruction and 1 with bilateral ureteral obstruction.
In this single-arm clinical trial, BWL was performed under general anesthesia in treatments ≤90 min. Outcomes included apparent fragmentation, ureterolith passage, decrease in pyelectasia or hydroureter, and decrease in serum creatinine concentration. Adverse events were characterized by severity and relationship to BWL.
In total, 12 ureters with 17 ureteroliths were treated with BWL. Five ureters received 1 treatment, 6 received 2, and 1 received 3, resulting in 20 total treatments. Ureterolith fragmentation was apparent in 11 of 12 treated ureters. Of 10 ureters with follow-up imaging, 8 had ureterolith passage and an accompanying decrease in ureteral dilatation. For the cats with ureterolith passage, the median serum creatinine concentration change was -29% (range, -56% to 28%) at 1-3 weeks. One serious BWL-related adverse event of worsening obstruction from residual fragments occurred, but was solved with retreatment.
Burst wave lithotripsy shows promise as a minimally invasive treatment for obstructive ureteroliths in cats. With the system used in our study, more than 1 treatment was often necessary.

PMID:
42424598
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.